The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Imatinib plasma concentrations during long-term effective treatment of metastatic gastrointestinal stromal tumor.
Akira Sawaki
No relevant relationships to disclose
Kazuki Inaba
No relevant relationships to disclose
Katsumi Hayashi
No relevant relationships to disclose
Hiroshi Kanie
No relevant relationships to disclose
Toshihiro Owaki
No relevant relationships to disclose
Tsukasa Kimata
No relevant relationships to disclose
Masato Suzuki
No relevant relationships to disclose
Aya Kawachi
No relevant relationships to disclose
Etsuro Orito
No relevant relationships to disclose